Fri, Oct 24, 2014, 7:32 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Gilead Sciences Inc. Message Board

  • going1green going1green May 9, 2013 8:18 AM Flag

    FDA nSends Letter to GILD About Lab reports & Now Insiders Selling.. LINK

    Market Watch 5/3/13
    FDA letter, earnings disappointment don’t slow down Gilead shares
    May 3, 2013, 11:39 AM
    By Russ Britt
    Investors nevertheless pushed the stock up another 7%, still euphoric over Gilead’s new hepatitis C drug, sofosbuvir, that seems to be coasting through the trial stage. The company on Thursday morning reported highly successful results for sofosbuvir in trials, curing at least 95% of those in various types of tests and 100% in some cases. When it reported earnings after the close, however, the news wasn’t as bright.
    The company said in a conference call with analysts that the FDA sent a letter raising concerns about lab records and test procedures at the Foster City facility. Dow Jones quoted Executive Vice President Norbert Bischofberger as calling the FDA letter a “little setback.”

    SortNewest  |  Oldest  |  Most Replied Expand all replies
110.71+3.53(+3.29%)Oct 24 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.